2021年食管癌临床治疗进展  

An annual review of advances in esophageal cancer in 2021

作　　者：焦曦 鲁智豪[1] Jiao Xi;Lu Zhihao(Department of Gastrointestinal Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital&Institute,Beijing 100142,China)

机构地区：[1]北京大学肿瘤医院暨北京市肿瘤防治研究所消化肿瘤内科,恶性肿瘤发病机制及转化研究教育部重点实验室,北京100142

出　　处：《肿瘤综合治疗电子杂志》2022年第1期61-71,共11页Journal of Multidisciplinary Cancer Management(Electronic Version)

基　　金：国家自然科学基金面上项目(82073230)。

摘　　要：2021年食管癌领域重磅研究层出不穷,在手术治疗、围手术期策略、根治性放化疗、联合免疫治疗、靶向治疗和多学科治疗等领域均有令人瞩目的成果。本文将梳理2021年食管癌领域的最新进展,并对这些研究进行盘点和解读,以提高大家对食管癌综合治疗的认识,推动食管癌的精准治疗。In 2021,unprecedented advances have been made in esophageal cancer treatment with the use of current treatment modalities,including surgery,perioperative treatment,radical radio-chemotherapy,combined immunotherapy,targeted therapy,and multidisciplinary treatment.In this review,we provide a summary of progress in 2021 and insights into esophageal cancer,which is significant for our understanding of multimodal management and precision medicine.

关 键 词：食管癌 围手术期治疗 联合免疫治疗 精准免疫治疗 

分 类 号：R735.1[医药卫生—肿瘤]